在骨质疏松中优化距离半径骨折的治疗策略:比较综述
Eric J Gullborg1, Jason H Kim1, Caitlin M Ward1
1Department of Orthopaedic Surgery, Rush University Medical Center, Chicago, IL 60612, USA.
Medicina (Kaunas, Lithuania)
|November 27, 2024
概括
在骨质疏松症患者中管理远半径骨折 (DRF) 需要个性化护理. 手术和非手术方法都能有效地适应患者的需要,优化结果并防止进一步的骨折.
科学领域:
- 整形外科 整形外科 整形外科
- 老年医学 老年医学
- 骨健康 骨健康 骨健康
背景情况:
- 骨质疏松症是一种普遍的疾病,导致骨折风险增加,特别是远半径骨折 (DRF).
- 骨质疏松症中骨质的质量变化使DRF管理复杂化,影响愈合和固定.
- 骨质疏松性骨折是常见的骨质疏松性骨折,可能表明随后严重骨折的风险更高.
研究的目的:
- 审查骨质疏松症患者DRF的手术和非手术管理策略.
- 突出个性化治疗选择对优化治疗结果的关键作用.
- 讨论在骨质疏松骨的背景下不同管理方法的挑战和好处.
主要方法:
- 在骨质疏松患者中对远端半径骨折管理研究的综合文献综述.
- 对手术干预的分析,包括开放式缩减和内置固定 (ORIF) 用.
- 评估基于患者因素的非手术治疗策略及其适用性.
主要成果:
- 手术管理 (ORIF) 可以实现早期动员和更好的调整,特别是对于活跃的患者.
- 与骨质疏松症相关的并发症,如硬件故障和感染,是手术固定的风险.
- 非手术治疗可能适合功能要求较低或手术风险较高的患者,尽管手术不良是令人担忧的.
结论:
- 个性化治疗策略对于骨质疏松患者的DRF管理至关重要.
- 优化结果需要仔细考虑患者的特征,功能需求和手术风险.
- 无论是手术还是非手术治疗,如果根据个体量身定制,都可以成功,从而有可能预防未来的骨折.
更多相关视频
09:02Cortical Bone Assessment Using Ultrasonic Guided Waves: A Reproducibility Study in a Healthy Population
Published on: January 31, 2025
411
06:59Author Spotlight: An Economic and Efficient Method for Quantitative Evaluation of Bone Microarchitecture in a Murine Osteoporosis Model
Published on: September 8, 2023
2.2K
相关概念视频
Fractures: Bone Repair
2.9K
Treatment for a fracture is based on the type of break, the bone affected, and the patient's age.
Minor fractures with no bone displacement are treated by immobilizing the fractured bone using a cast or splint. However, in the case of fractures with displaced bones, the broken bones are repositioned before immobilization to ensure successful healing without deformation and loss of function. The realignment of fractured bone ends is performed through a process called reduction. If the...
Minor fractures with no bone displacement are treated by immobilizing the fractured bone using a cast or splint. However, in the case of fractures with displaced bones, the broken bones are repositioned before immobilization to ensure successful healing without deformation and loss of function. The realignment of fractured bone ends is performed through a process called reduction. If the...
2.9K
Osteoclasts in Bone Remodeling
2.8K
Osteoclasts are cells responsible for bone resorption and remodeling. They originate from hematopoietic progenitor cells present in the bone marrow. Numerous progenitor cells fuse to form multinucleated cells, each with 10-20 nuclei. A single osteoclast has a diameter of 150 to 200 µM. These cells have ruffled borders that break down the underlying bone tissue and release minerals such as calcium into the blood in bone resorption. Osteoclasts cling to bones with their ruffled edges during...
2.8K
Bone Disorders
3.4K
Aging and its effect on bone remodeling is the most common cause of bone disorders. In young and healthy people, bone deposition and resorption happen at an equal rate to maintain optimal bone health.
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
3.4K
